Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Barton Grossman

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
The Journal of Urology|April 11, 2003
Immunotherapy for bladder cancer. Is the black box becoming grayer?H Barton Grossman
Drugs of Today (Barcelona, Spain : 1998)|May 6, 2003
Selective COX-2 inhibitors as chemopreventive and therapeutic agentsH Barton Grossman
Urology|March 15, 2006
Chemoprevention of bladder cancerH Barton Grossman
Urology|October 6, 2009
Editorial commentH Barton Grossman
The Lancet. Oncology|August 12, 2011
Bladder cancer: neoadjuvant is new againH Barton Grossman
European Urology|October 23, 2010
Words of wisdom. Re: reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-GuérinH Barton Grossman
The Journal of Urology|March 7, 2017
Editorial CommentH Barton Grossman
European Urology|December 13, 2007
Words of wisdom. Re: radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder casesH Barton Grossman
The Journal of Urology|November 17, 2009
Are biomarkers for bladder cancer beneficial?H Barton Grossman
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|August 30, 2007
Improving the management of bladder cancer with fluorescence cystoscopyH Barton Grossman
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
The Journal of Urology|April 11, 2003
Immunotherapy for bladder cancer. Is the black box becoming grayer?H Barton Grossman
Drugs of Today (Barcelona, Spain : 1998)|May 6, 2003
Selective COX-2 inhibitors as chemopreventive and therapeutic agentsH Barton Grossman
Urology|March 15, 2006
Chemoprevention of bladder cancerH Barton Grossman
Urology|October 6, 2009
Editorial commentH Barton Grossman
The Lancet. Oncology|August 12, 2011
Bladder cancer: neoadjuvant is new againH Barton Grossman
European Urology|October 23, 2010
Words of wisdom. Re: reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-GuérinH Barton Grossman
The Journal of Urology|March 7, 2017
Editorial CommentH Barton Grossman
European Urology|December 13, 2007
Words of wisdom. Re: radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder casesH Barton Grossman
The Journal of Urology|November 17, 2009
Are biomarkers for bladder cancer beneficial?H Barton Grossman
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|August 30, 2007
Improving the management of bladder cancer with fluorescence cystoscopyH Barton Grossman
Pageof 21